azomycin has been researched along with ruthenium in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, PK; James, BR; Skov, KA | 1 |
| Chan, PK; Farrell, NP; James, BR; Skov, KA | 2 |
| James, BR; Kennedy, DC; Patrick, BO; Wu, A | 1 |
| Anzellotti, A; Azqueta, A; Cabrera, E; Cerecetto, H; Gambino, D; González, M; López de Ceráin, A; Monge, A; Noblia, P; Otero, L; Parajón-Costa, B; Sánchez-Delgado, R | 1 |
| Brindell, M; Maciuszek, M; Mazuryk, O; Stochel, G; Suzenet, F | 1 |
| Carneiro, ZA; da Silva, RS; Milanezi, C; Santos, M; Sesti-Costa, R; Silva, GK; Silva, JS; Silva, MC | 1 |
| Hara, D; Ito, T; Kawasaki, A; Son, A; Tanabe, K | 1 |
| Brindell, M; Kieda, C; Mazuryk, O; Suzenet, F | 1 |
| Carneiro, ZA; Carvalho, I; Carvalho, MR; de Andrade, P; de Melo, EB; Galo, OA; Lopes, CD; Sesti-Costa, R; Silva, JS | 1 |
| Brindell, M; Brzozowski, T; Krysiak-Foria, O; Mazuryk, O; Ptak-Belowska, A; Stochel, G; Suzenet, F; Żak, A | 1 |
| Kurihara, R; Son, A; Takagi, K; Tanabe, K; Yoshihara, K | 1 |
| Conti, L; Fagorzi, C; Giacomazzo, GE; Giorgi, C; Guerri, A; Mengoni, A; Pagliai, M; Palchetti, I; Pietraperzia, G; Sfragano, PS; Valtancoli, B | 1 |
13 other study(ies) available for azomycin and ruthenium
| Article | Year |
|---|---|
Further studies on toxic and radiosensitizing properties of ruthenium complexes of 4-nitroimidazoles.
Topics: Animals; Cricetinae; Cricetulus; Dose-Response Relationship, Radiation; Female; Fibroblasts; Nitroimidazoles; Ovary; Oxygen; Radiation-Sensitizing Agents; Ruthenium | 1987 |
A new ruthenium radiosensitizer: RuCl2(DMSO)2(4-nitroimidazole)2.
Topics: Animals; Cell Survival; Cricetinae; In Vitro Techniques; Nitroimidazoles; Organometallic Compounds; Radiation-Sensitizing Agents; Ruthenium | 1986 |
Chromosome-damaging activity of a ruthenium radiosensitizer, RuCl2 (DMSO)2 (4-nitroimidazole)2, in Chinese hamster ovary cells in vitro.
Topics: Animals; Chromosome Aberrations; Cisplatin; Cricetinae; Cricetulus; Female; In Vitro Techniques; Misonidazole; Mutagens; Nitroimidazoles; Organometallic Compounds; Ovary; Radiation-Sensitizing Agents; Ruthenium | 1986 |
Ruthenium(II) sulfoxide-maltolato and -nitroimidazole complexes: synthesis and MTT assay.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Structure; Nitroimidazoles; Organometallic Compounds; Pyrones; Ruthenium; Stereoisomerism; Sulfoxides; Tetrazolium Salts; Thiazoles | 2003 |
Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Survival; DNA; DNA Adducts; Drug Screening Assays, Antitumor; Nitroimidazoles; Organometallic Compounds; Oxidation-Reduction; Ruthenium; Tumor Cells, Cultured | 2004 |
2-Nitroimidazole-ruthenium polypyridyl complex as a new conjugate for cancer treatment and visualization.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Coordination Complexes; Humans; Inhibitory Concentration 50; Kinetics; Luminescent Measurements; Mice; Molecular Imaging; Nitroimidazoles; Protein Binding; Pyridines; Ruthenium; Serum Albumin | 2014 |
Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.
Topics: Animals; Chagas Disease; Drug Resistance; Drug Therapy, Combination; Female; Heart; Humans; Inflammation; Mice; Nitric Oxide; Nitroimidazoles; Parasitemia; Ruthenium; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
Phosphorescent ruthenium complexes with a nitroimidazole unit that image oxygen fluctuation in tumor tissue.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Coordination Complexes; Energy Transfer; Female; Green Fluorescent Proteins; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Neoplasms; Nitroimidazoles; Optical Imaging; Oxygen; Ruthenium; Transplantation, Heterologous | 2015 |
The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
Topics: Animals; Apoptosis; Cell Adhesion; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cisplatin; Coordination Complexes; Endocytosis; Endothelial Cells; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Mice; Microscopy, Fluorescence; Neoplasms; Neovascularization, Physiologic; Nitroimidazoles; Oxidative Stress; Pyridines; RNA, Messenger; Ruthenium; Subcellular Fractions; Wound Healing | 2015 |
1,2,3-Triazole-based analogue of benznidazole displays remarkable activity against Trypanosoma cruzi.
Topics: Catalysis; Click Chemistry; Copper; Cycloaddition Reaction; Microwaves; Nitroimidazoles; Ruthenium; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Nitroimidazole derivatives of polypyridyl ruthenium complexes: Towards understanding their anticancer activity and mode of action.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; Mitochondria; Nitroimidazoles; Phenanthrolines; Reactive Oxygen Species; Ruthenium; S Phase | 2017 |
Aggregate Formation of Oligonucleotides that Assist Molecular Imaging for Tracking of the Oxygen Status in Tumor Tissue.
Topics: A549 Cells; Animals; Coordination Complexes; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Light; Luminescent Agents; Mice, Inbred BALB C; Molecular Imaging; Nitroimidazoles; Oligodeoxyribonucleotides; Oxazines; Oxygen; Pyrenes; Ruthenium; Tumor Hypoxia | 2017 |
Nitroimidazole-Based Ruthenium(II) Complexes: Playing with Structural Parameters to Design Photostable and Light-Responsive Antibacterial Agents.
Topics: Anti-Bacterial Agents; Coordination Complexes; Ligands; Nitroimidazoles; Ruthenium | 2022 |